Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase NA 2Phase 3 2Phase 2/3 2Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1

Status

Completed 12Terminated 4Active not recruiting 4Not yet recruiting 3Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1Colorectal Cancer Liver Metastases 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 90Gemcitabine 81Paclitaxel 80Docetaxel 73Capecitabine 64Oxaliplatin 53Specimen Handling 52Fluorouracil 52Magnetic Resonance Spectroscopy 50Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 44Leucovorin 39Drug Therapy 39Irinotecan 37Doxorubicin 36Pemetrexed 35Injections 30Trastuzumab 28Vincristine 27Rituximab 27Radiosurgery 25Prednisone 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × regorafenib × Clear all
NCT06992648 2025-05-28

REGTAS-2

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 3 Recruiting
302 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05794971 2023-05-15

RIDER

Sun Yat-sen University

Phase 3 Recruiting
126 enrolled
Gastrointestinal

Colorectal Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡